Literature DB >> 3677574

Serratia bacteremia.

E Bouza1, M García de la Torre, A Erice, E Cercenado, E Loza, M Rodríguez-Créixems.   

Abstract

During a 6-yr period, 146 patients at our institution had Serratia bacteremia (3.8% of the total number of episodes of bacteremia), with an incidence of 1.24/1000 admitted patients. We chose a random group of 50 cases for clinical analysis in the present study. The disease was community-acquired in 8% of the cases and nosocomially-acquired in the remaining 92%. The bacteremia was unimicrobial in 84% and part of a polymicrobial bacteremia in 16% of the episodes. The most frequently isolated species of the Serratia genus was S. marcescens. Portals of entry, in decreasing order of frequency, were: urinary, unknown, respiratory, and surgical wound infections. Clinically, the most frequent finding was fever (100%). Shock occurred in 28% of the patients, and none of our cases showed evidence of disseminated intravascular coagulation. We found 62% of Serratia isolates resistant to gentamicin. Overall mortality was 38% and factors associated with a poor prognosis were: severity of the underlying disease, critical clinical situation at onset of bacteremia, presence in the intensive care unit (I.C.U.), occurrence of shock or polymicrobial bacteremia, portal of entry in the respiratory tract, and inadequate treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3677574     DOI: 10.1016/0732-8893(87)90138-6

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  7 in total

1.  Serratia sp. bacteremia in Canberra, Australia: a population-based study over 10 years.

Authors:  H J Engel; P J Collignon; P T Whiting; K J Kennedy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-05       Impact factor: 3.267

2.  Case-control analysis of endemic Serratia marcescens bacteremia in a neonatal intensive care unit.

Authors:  Matthew J Bizzarro; Louise-Marie Dembry; Robert S Baltimore; Patrick G Gallagher
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-11-06       Impact factor: 5.747

3.  Serratia infections in patients with neutropenia.

Authors:  F Hartmann; T Gheorghiu; H Leupold; F Baer; V Diehl
Journal:  Klin Wochenschr       Date:  1991-08-01

4.  Population-based laboratory surveillance for Serratia species isolates in a large Canadian health region.

Authors:  K B Laupland; M D Parkins; D B Gregson; D L Church; T Ross; J D D Pitout
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10-25       Impact factor: 3.267

Review 5.  Clinical implications of positive blood cultures.

Authors:  C S Bryan
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

6.  Community-acquired Serratia marcescens spinal epidural abscess in a patient without risk factors: Case report and review.

Authors:  Michael D Parkins; Daniel B Gregson
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-05       Impact factor: 2.471

7.  Serratia marcescens Peritonitis in a Diabetic Patient Receiving Continuous Ambulatory Peritoneal Dialysis.

Authors:  Ji Hyoun Kang; Min Jee Kim; Yong Un Kang; Chang Seong Kim; Joon Seok Choi; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  Infect Chemother       Date:  2013-03-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.